C.R.S. § 25-1.5-115.3

(1) For the 2022-23 state fiscal year, the general assembly shall appropriate six hundred thousand dollars to the department for the purpose of purchasing non-laboratory synthetic opiate detection tests. Any unexpended money remaining at the end of the 2022-23 state fiscal year from this appropriation: (a) Does not revert to the general fund or any other fund; (b) May be used by the department in the 2023-24 state fiscal year without further appropriation; and (c) Must not be used for any other purpose other than the purpose set forth in this section. (2) The department shall distribute the non-laboratory synthetic opiate detection tests to eligible entities. The department may prioritize the distribution of non-laboratory synthetic opiate detection tests to eligible entities based on the need of each entity and the availability of the non-laboratory synthetic opiate detection tests as determined by the department. (3) As used in this section, unless the context otherwise requires: (a) “Eligible entity” means a person or entity described in section 12-30-110 (1)(a); except that an employee or agent of a school must be acting in accordance with section 12-30-110 (1)(b), (2)(b), or (4)(b), and, as applicable, section 22-1-119.2 . (b) “Non-laboratory synthetic opiate detection test” means a product that is intended or designed to detect the presence of a synthetic opiate. (4) This section is repealed, effective July 1, 2024.